Scientific work

Prof. Dr. Özlem Mutluay Soyer

108 publications. The source of the information is stated next to each publication.

Back to profile

  1. MUTLUAY SOYER OZLEM, BARAN BULENT, ORMECİ ASLI CIFCIBASI, SAHİN DAVUT, GOKTURK SUUT, EVİRGEN SAMİ, BASAR RAFET, FIRAT PINAR, AKYUZ FİLİZ, DEMİR KADİR, BESISIK FATİH, KAYMAKOGLU SABAHATTİN, KARACA CETİN. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study. Medicine (Baltimore). 2017 Jan;96(1):e5513. doi: 10.1097/MD.0000000000005513.

    Source: medicana.com.tr profile page

  2. ORMECİ ASLI, AYDIN YÜCEL, SUMNU ABDULLAH, BATAN BULENT, MUTLUAY SOYER OZLEM, PINARBASI BİNNUR, GOKTURK SUUT, GULLUOGLU MİNE, ONEL DERYA, BADUR SELİM, AKYUZ FİLİZ, KARACA CETİN, DEMİR KADİR, BESISIK FATİH, KAYMAKOGLU SABAHATTİN. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels. Int J Infect Dis. 2016 Nov;52:68-73. doi: 10.1016/j.ijid.2016.09.007.

    Source: medicana.com.tr profile page

  3. KARACA CETİN, DAGLILAR EBUBEKIR, MUTLUAY SOYER OZLEM, GULLUOGLU MİNE, BRUGGE WİLLİAM R. Endoscopic submucosal resection of gastric subepithelial lesions smaller than 20 mm: a comparison of saline solution-assisted snare and cap band mucosectomy techniques.Gastrointest Endosc. 2016 Sep 20. pii: S0016-5107(16)30585-5. doi: 10.1016/j.gie.2016.09.016.

    Source: medicana.com.tr profile page

  4. MUTLUAY SOYER OZLEM, PEHLİVAN ASLI, CIFCIBASI ORMECI, BARAN BULENT, SAHİN TOLGA Rabbit syndrome developing during peginterferon alfa-2a use in chronic hepatitis C. Curr Med Res Opin. 2017 Jan;33(1):55-56. DOI:10.1080/03007995.2016.1233100.

    Source: medicana.com.tr profile page

  5. MUTLUAY SOYER ÖZLEM,BARAN BULENT,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,AYDIN ESRA, ÖNEL DERYA,GÜLLÜOGLU MINE,KARACA ÇETIN,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2016). Comparison of the efficacy of 12 months and

    Source: medicana.com.tr profile page

  6. longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study. Postgraduate Medicine, 1-7., Doi: 10.1080/00325481.2016.1175310.

    Source: medicana.com.tr profile page

  7. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT, EVIRGEN SAMI,BOZBEY HAMZA UGUR,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH, ÖNEL DERYA,GÜLLÜOGLU MINE,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2013). Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B. Antimicrobial Agents and Chemotherapy, 57(4), 1790-1796., Doi: 10.1128/AAC.02600-12.

    Source: medicana.com.tr profile page

  8. BARAN BULENT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,ÖNEL DERYA, GÜLLÜOGLU MINE,BADUR SELIM,KAYMAKOGLU SABAHATTIN (2015). Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B

    Source: medicana.com.tr profile page

  9. virus. Liver International, 35(10), 2265-2274., Doi: 10.1111/liv.1283.

    Source: medicana.com.tr profile page

  10. KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,BARAN BÜLENT,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,AYDIN ESRA,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2012). Efficacy of peginterferon alpha treatment for 24 months in chronic delta hepatitis and predictors of response. Antiviral Therapy, 18(4), 561-566.,

    Source: medicana.com.tr profile page

  11. BARAN BÜLENT,GÜLLÜOGLU MINE,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,YESIL SEMEN,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2014). Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C. Journal of Viral Hepatitis, 21(2),

    Source: medicana.com.tr profile page

  12. YILMAZ EMRE,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,ÖNEL MUSTAFA,ÖNEL DERYA,ÇIFCIBASI ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN,KARACA ÇETIN (2014). Effects of Polymorphisms in Interferon λ 3(Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection. Clinical Gastroenterology and Hepatology, 12(10), 1753-1758., Doi: 10.1016/j.cgh.2014.01.043.

    Source: medicana.com.tr profile page

  13. ÇIFCIBASI ÖRMECI ASLI,AKYÜZ FILIZ,BULENT BARAN,MUTLUAY SOYER ÖZLEM,GÖKTÜRK SUUT,ÖNEL MUSTAFA,ÖNEL DERYA,AGAÇFIDAN ALI,DEMIRCI MEHMET,YEGEN GÜLÇIN,GÜLLÜOGLU MINE,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH, KAYMAKOGLU SABAHATTIN (2016). Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. European Review for Medical and Pharmacological Sciences.

    Source: medicana.com.tr profile page

  14. ÖRMECI ASLI,EMRENCE ZELIHA,BARAN BULENT,SUUT GÖKTÜRK,MUTLUAY SOYER ÖZLEM, EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN, ÜSTEK DURAN,DEMIR KADIR (2016). Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. European Review for Medical and Pharmacological Sciences.

    Source: medicana.com.tr profile page

  15. DEMIR ABDURRAHMAN,AKYÜZ FILIZ,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ ÜMIT,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN,DEMIR KADIR,GÜNDOGDU GÖKCEN,GÜLLÜOGLU MINE, ERER SAIT BURAK,KAMALI SEVIL,KAYMAKOGLU SABAHATTIN, BESISIK SELMAN FATIH,GÜL AHMET(2014). Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scandinavian Journal of Gastroenterology, 49(12), 1414-1418., Doi:10.3109/00365521.2014.976838.

    Source: medicana.com.tr profile page

  16. ÖRMECI ASLI,AKYÜZ FILIZ,BARAN BÜLENT,GÖKTÜRK SUUT,ÖRMECI TUGRUL,PINARBASI BINNUR,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,AKYÜZ ÜMIT,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2016). What is the impact of capsule endoscopy in the long term period?. World Journal of Gastrointestinal Endoscopy, 8(7), 344, Doi: 10.4253/wjge. v8.i7.344.

    Source: medicana.com.tr profile page

  17. BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,POYANLI ARZU,KARACA ÇETIN (2013). Angiographic embolization of large duodenal varix in a cirrhotic patient. Digestive and Liver Disease, 45

    Source: medicana.com.tr profile page

  18. (5), 437, Doi: 10.1016/j.dld.2012.10.001.

    Source: medicana.com.tr profile page

  19. BARAN BULENT,MUTLUAY SOYER ÖZLEM,KARACA ÇETIN (2013). Terry's nail: an overlooked

    Source: medicana.com.tr profile page

  20. physical finding in cirrhosis. Hepatobiliary & Pancreatic Diseases International, 12(1), 109, Doi:

    Source: medicana.com.tr profile page

  21. 10.1016/S1499-3872(13)60017-X, (Kontrol No: 2701720)

    Source: medicana.com.tr profile page

  22. KARACA ÇETIN,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM (2012). Unusual location of

    Source: medicana.com.tr profile page

  23. polypectomy with an ultra-slim gastroscope: Biliary polyp (with video). Digestive Endoscopy, 24(6), 477-477., Doi: 10.1111/j.1443-1661.2012.01323.x.

    Source: medicana.com.tr profile page

  24. BARAN BULENT,KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,LAÇIN SAHIN,DEMIR KADIR,BESISIK SELMAN FATIH,BOZTAS GÜNGÖR (2012). Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: A case report. Clinics and Research in Hepatology and Gastroenterology, 36(4), 69-70., Doi: 10.1016/j.clinre.2012.01.002.

    Source: medicana.com.tr profile page

  25. BARAN BÜLENT,KARACA ÇETIN,MUTLUAY SOYER ÖZLEM,YÖNAL IPEK,ISIKLAR AYSUN,ÇAKMAK RAMAZAN,NALÇACI MELIHA,DOGAN ÖNER,KAYMAKOGLU SABAHATTIN (2013). Rosai–Dorfman disease with diffuse gastrointestinal involvement. European Journal of Gastroenterology & Hepatology, 25(7), 869-874., Doi: 10.1097/MEG.0b013e32836019f8.

    Source: medicana.com.tr profile page

  26. ASLI ÇIFCIBASI ÖRMECI, EMRENCE ZELIHA, BÜLENT BARAN, SOYER ÖZLEM, GÖKTÜRK SUUT, EVIRGEN SAMI, AKYÜZ FILIZ, KARACA ÇETIN, BESISIK SELMAN FATIH, KAYMAKOGLU

    Source: medicana.com.tr profile page

  27. SABAHATTIN, ÜSTEK DURAN, DEMIR KADIR (2016). Can helicobacter pylori be eradicated with

    Source: medicana.com.tr profile page

  28. high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotipic

    Source: medicana.com.tr profile page

  29. polymorphism?. European Review for Medical and Pharmacological Sciences,

    Source: medicana.com.tr profile page

  30. ÖRMECI ASLI,AKYÜZ FILIZ,BARAN BÜLENT,GÖKTÜRK SUUT,ÖRMECI TUGRUL,PINARBASI BINNUR,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,AKYÜZ ÜMIT,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLUSABAHATTIN,BESISIK SELMAN FATIH (2016). Retention during capsule endoscopy: Is it a real problem in routine practice?. Journal of International Medical Research, Doi: 10.1177 /0300060516645420.

    Source: medicana.com.tr profile page

  31. GÖKTÜRK SUUT,ATAY KADRI,ÖRMECI ASLI,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,KAYMAKOGLU SABAHATTIN (2011). A rare complication of interferon treatment: optic neuropathy. Annals of Gastroenterology.

    Source: medicana.com.tr profile page

  32. AKYÜZ F, MUTLUAY SOYER Ö (2017). Which diseases are risk factors for developing gastroesophageal reflux disease? Akyüz F, Mutluay Soyer Ö. Turk J Gastroenterol.Dec;28(Suppl 1):S44-S47. doi:10.5152/tjg.2017.12. Review

    Source: medicana.com.tr profile page

  33. AKYÜZ F, MUTLUAY SOYER Ö (2017). How is gastroesophageal reflux disease classified? Akyüz F, Mutluay Soyer Ö. Turk J Gastroenterol. Dec;28(Suppl 1):S10-S11. doi: 10.5152/tjg.2017.04. Review.

    Source: medicana.com.tr profile page

  34. EKINCI OMER, BARAN BULENT, ORMECI AC, SOYER OM, GOKTURK S,POYANLI A, AKYUZ F, KARACA C,DEMİR K, KAYMAKOGLU S (2018). Current State and Clinical Outcome in Turkish Patients with Hepatoceluler Carsinoma. World J.Hepatol. Jan 27;10(1):51-61.

    Source: medicana.com.tr profile page

  35. İLİAZ R, AKYÜZ F, YEĞEN G, ÖRMECİ A, GÖKTÜRK S, AKYÜZ Ü, BARAN B, MUTLUAY Ö, EVİRGEN S, KARACA Ç, DEMİR K, BEŞIŞIK F, GÜLLÜOĞLU M, KAYMAKOĞLU S( 2018). Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? Turk J Gastroenterol. Jul;29(4):384-391. doi: 10.5152/tjg.2018.17491.

    Source: medicana.com.tr profile page

  36. GÖKTÜRK S, AKYÜZ F, ARICI S, ALPASLAN B, ÖRMECİ A, SOYER OM, EVİRGEN S, ÇAVUŞ B, ÜZÜM AK, GÜL N, AKYÜZ Ü, KARACA Ç, DEMİR K, KAYMAKOĞLU S, SATMAN İ, BEŞIŞIK F (2018). Gastroesophageal Reflux in Asymptomatic Patients with Diabetes: An Impedance Study Diabetes, Obesity and Gastroesophageal Reflux. Exp Clin Endocrinol Diabetes. 2018 Nov 20. doi: 10.1055/a-0783-2327.

    Source: medicana.com.tr profile page

  37. B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler :

    Source: medicana.com.tr profile page

  38. KARACA ÇETIN,YILMAZ EMRE,MUTLUAY SOYER ÖZLEM,ÖNEL DERYA,ÖNEL MUSTAFA, BARAN BÜLENT,ÖRMECI ASLI,GÖKTÜRK SUUT,EVIRGEN SAMI,AKYÜZ FILIZ,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). IL28B Polymorphisms and Influence on Sustained Virological Response to Interferon Therapy in Chronic DELTA Hepatitis.

    Source: medicana.com.tr profile page

  39. 2.ÖRMECI ASLI,GÖKTÜRK SUUT,AKYÜZ FILIZ,GÜLLÜOGLU MINE,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,BESISIK SELMAN FATIH (2012). When we should start antiviral treatment in CMV positive

    Source: medicana.com.tr profile page

  40. inflammatory bowel disease?. UEG WEEK 2012 (Poster).

    Source: medicana.com.tr profile page

  41. DEMIR KADIR,ÖRMECI ASLI,EMRENCE ZELIHA,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN,ÜSTEK DURAN (2013). Effect of Genotypic Differences in CYP2C19 and on Cure Rates for

    Source: medicana.com.tr profile page

  42. Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors.

    Source: medicana.com.tr profile page

  43. ÖZDIL SADAKAT,MUTLUAY SOYER ÖZLEM,AKYÜZ FILIZ,KARACA ÇETIN,BARAN BÜLENT,GÖKTÜRKSUUT,EVIRGEN SAMI,DEMIR KADIR (2012). Natural course in Crohn’s disease under the conventional Therapy. FALK SYMPOSIUM 2012 (Poster).

    Source: medicana.com.tr profile page

  44. GÖKTÜRK SUUT,BESISIK SELMAN FATIH,ARICI SERPIL,ALPASLAN BÜSRA,ÖRMECI ASLI,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,ÇAVUS BILGER,KUBAT ÜZÜM AYSE,GÜL NURDAN,AKYÜZ ÜMIT, KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU SABAHATTIN,SATMAN ILHAN (2014). Is Diabetes Mellitus a Risk Factor for Gastroesophageal Reflux?. DIGESTIVE DISEASE WEEK 2014 (Poster)

    Source: medicana.com.tr profile page

  45. AKYÜZ FILIZ,ÖRMECI ASLI,KARACA ÇETIN,GÖKTÜRK SUUT,BARAN BÜLENT,MUTLUAY SOYER ÖZLEM,EVIRGEN SAMI,ÖRMECI TUGRUL,POYANLI ARZU,GÜLLÜOGLU MINE,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2013). A disease with a wide range of clinical presentation: IgG4 related disease. APASL LIVER WEEK 2013 (Poster)

    Source: medicana.com.tr profile page

  46. GÖKTÜRK SUUT,MUTLUAY SOYER ÖZLEM,ÇIFCIBASI ÖRMECI ASLI,BARAN BÜLENT,EVIRGEN SAMI,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,BESISIK SELMAN FATIH,KAYMAKOGLU SABAHATTIN (2016). Efficacy of infliximab treatment in acute severe ulcerative colitis. 8th Congress of ECCO 2013 (Poster).

    Source: medicana.com.tr profile page

  47. BARAN BÜLENT,GÜLLÜOGLU MINE,MUTLUAY SOYER ÖZLEM,ÖRMECI ASLI,GÖKTÜRK SUUT,

    Source: medicana.com.tr profile page

  48. EVIRGEN SAMI,YESIL SEMEN,AKYÜZ FILIZ,KARACA ÇETIN,DEMIR KADIR,KAYMAKOGLU

    Source: medicana.com.tr profile page

  49. SABAHATTIN,BESISIK SELMAN FATIH (2013). Treatment failure may lead to accelerated

    Source: medicana.com.tr profile page

  50. fibrosis progression in patients with chronic hepatitis C. EASL 2013 (Poster).

    Source: medicana.com.tr profile page